These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21181122)

  • 1. Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine.
    Calabrese F; Molteni R; Gabriel C; Mocaer E; Racagni G; Riva MA
    Psychopharmacology (Berl); 2011 May; 215(2):267-75. PubMed ID: 21181122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice.
    Païzanis E; Renoir T; Lelievre V; Saurini F; Melfort M; Gabriel C; Barden N; Mocaër E; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2010 Jul; 13(6):759-74. PubMed ID: 19775499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agomelatine (S20098) modulates the expression of cytoskeletal microtubular proteins, synaptic markers and BDNF in the rat hippocampus, amygdala and PFC.
    Ladurelle N; Gabriel C; Viggiano A; Mocaër E; Baulieu EE; Bianchi M
    Psychopharmacology (Berl); 2012 Jun; 221(3):493-509. PubMed ID: 22160164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes.
    Milanese M; Tardito D; Musazzi L; Treccani G; Mallei A; Bonifacino T; Gabriel C; Mocaer E; Racagni G; Popoli M; Bonanno G
    BMC Neurosci; 2013 Jul; 14():75. PubMed ID: 23895555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration.
    Molteni R; Calabrese F; Pisoni S; Gabriel C; Mocaer E; Racagni G; Riva MA
    World J Biol Psychiatry; 2010 Mar; 11(2):148-53. PubMed ID: 20109111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agomelatine-induced modulation of brain-derived neurotrophic factor (BDNF) in the rat hippocampus.
    Lu Y; Ho CS; McIntyre RS; Wang W; Ho RC
    Life Sci; 2018 Oct; 210():177-184. PubMed ID: 30193943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine.
    Lemoine P; Guilleminault C; Alvarez E
    J Clin Psychiatry; 2007 Nov; 68(11):1723-32. PubMed ID: 18052566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agomelatine treatment corrects impaired sleep-wake cycle and sleep architecture and increases MT
    Tchekalarova J; Kortenska L; Ivanova N; Atanasova M; Marinov P
    Psychopharmacology (Berl); 2020 Feb; 237(2):503-518. PubMed ID: 31720718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus.
    Soumier A; Banasr M; Lortet S; Masmejean F; Bernard N; Kerkerian-Le-Goff L; Gabriel C; Millan MJ; Mocaer E; Daszuta A
    Neuropsychopharmacology; 2009 Oct; 34(11):2390-403. PubMed ID: 19571795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
    Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD
    Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.
    Serres F; Millan MJ; Sharp T
    Int J Neuropsychopharmacol; 2012 Jun; 15(5):617-29. PubMed ID: 21733241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors.
    Racagni G; Riva MA; Molteni R; Musazzi L; Calabrese F; Popoli M; Tardito D
    World J Biol Psychiatry; 2011 Dec; 12(8):574-87. PubMed ID: 21999473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant drug treatment induces Arc gene expression in the rat brain.
    Pei Q; Zetterström TS; Sprakes M; Tordera R; Sharp T
    Neuroscience; 2003; 121(4):975-82. PubMed ID: 14580947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain.
    Dagyte G; Luiten PG; De Jager T; Gabriel C; Mocaër E; Den Boer JA; Van der Zee EA
    J Neurosci Res; 2011 Oct; 89(10):1646-57. PubMed ID: 21688292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats.
    Conboy L; Tanrikut C; Zoladz PR; Campbell AM; Park CR; Gabriel C; Mocaer E; Sandi C; Diamond DM
    Int J Neuropsychopharmacol; 2009 Apr; 12(3):329-41. PubMed ID: 18706130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats.
    Torregrossa MM; Isgor C; Folk JE; Rice KC; Watson SJ; Woods JH
    Neuropsychopharmacology; 2004 Apr; 29(4):649-59. PubMed ID: 14647482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice.
    Boulle F; Velthuis H; Koedam K; Steinbusch HW; van den Hove DLA; Kenis G; Gabriel C; Mocaer E; Franc B; Rognan D; Mongeau R; Lanfumey L
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):65-77. PubMed ID: 26653128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute onset by 5-HT(6)-receptor activation on rat brain brain-derived neurotrophic factor and activity-regulated cytoskeletal-associated protein mRNA expression.
    de Foubert G; O'Neill MJ; Zetterström TS
    Neuroscience; 2007 Jul; 147(3):778-85. PubMed ID: 17560041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel antidepressant agomelatine normalizes hippocampal neuronal activity and promotes neurogenesis in chronically stressed rats.
    Dagyte G; Trentani A; Postema F; Luiten PG; Den Boer JA; Gabriel C; Mocaër E; Meerlo P; Van der Zee EA
    CNS Neurosci Ther; 2010 Aug; 16(4):195-207. PubMed ID: 20236141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
    Larsen MH; Mikkelsen JD; Hay-Schmidt A; Sandi C
    J Psychiatr Res; 2010 Oct; 44(13):808-16. PubMed ID: 20172535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.